Constance Crowley

Constance Crowley has extensive experience in clinical operations and program management. Constance currently holds the position of Executive Director/Senior Clinical Scientist at Arcturus Therapeutics. Prior to that, they were the President of Clinical Consulting from 2019 to 2021. From 2016 to 2019, they worked as a Senior Clinical Operations Leader at Roche, where they managed the operational strategy for infectious diseases, inflammation, and immunology portfolios. Before that, they were again the President of Clinical Consulting from 2015 to 2016, where they worked as a clinical development consultant with expertise in various therapeutic areas. Constance also worked as a Consultant at Roche in 2014. From 2013 to 2014, they served as the Vice President of Program Management and Clinical Operations at Santaris Pharma, responsible for program and budget management. Prior to that, they worked as a Clinical Consultant at Nitto Denko in 2012, establishing clinical operations for a fibrosis project. From 2008 to 2012, they served as the Vice President of Clinical Operations at Anadys Pharmaceuticals. In 2004, they established a clinical presence at Kemia, Inc. as the Director of Clinical Research Program Management. Lastly, they worked as the Senior Director of Clinical Research at Maxim Pharmaceuticals, Inc. from 2002 to 2004.

Constance Crowley obtained their Bachelor of Science (B.S.) degree in Biology/Biological Sciences from Fairleigh Dickinson University, which they attended from 1967 to 1971. Prior to their university education, they also attended Northern Highlands Regional High School, although no specific years or degrees were mentioned.